Previous Close | 40.65 |
1-Year Change | 22.88% |
6-Months Change | 88.54% |
3-Months Change | 8.05% |
Moving Avg (50d) | 35.09 |
Moving Avg (200d) | 27.889 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.93B |
Beta (3-Years) | 1.26 |
Revenue Growth (ttm) | 20.65% |
Net Profit Margin (ttm) | -6.52% |
Return On Assets (ttm) | -4.13% |
EPS (ttm) | -0.54 |
PE Ratio (ttm) | -75.28 |
Dividend Yield | % |
Asset Description: | AtriCure, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2024-12-05 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
41.463 | 42.683 | 43.496 | 44.715 | 46.748 | 48.78 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.